CH Health Tech Advisory

Insights / Function

Market Access

Field notes on Market Access in life sciences — payer dynamics, HEOR, value frameworks, reimbursement strategy, and the rising cost of getting paid.

4 posts in Market Access

6 Mar 2025 · 1 min read

A very insightful panel at the EPA lconference in Amsterdam from Gavin Lewis of Novartis, Annett...

I attended a very insightful panel at the EPA conference in Amsterdam on how global healthcare reforms are impacting local market access strategy. Modeling demands are becoming more challenging, joined Health Technology Assessments are increasingly the rule, and — as Gavin Lewis of Novartis put it — your access strategy is becoming your entire enterprise strategy.